Regulation of Hematopoiesis in Cancer Patients: Placebo-Driven, Double-Blind Clinical Trials of β-Glucan

Vaclav Vetvicka, J Richter, V Král, L Dobiášová Rajnohová, I Stiborova, J Pohorska

Abstract


AIM: The role of glucan in the stimulation of immunity is well established, including oncological models. In this report, we focused on effects of glucan supplementation of cancer patients in post-treatment periods. MATERIALS AND METHODS: We measured the levels of C-reactive protein, ferritin, transferrin, soluble transferrin receptors, hemoglobin, total number of erythrocytes and index of sTfR/log ferritin. RESULTS: We found significant improvements in the levels of hemoglobin, total number of erythrocytes and index of sTfR/log ferritin. CONCLUSIONS: We concluded that the short 60 day supplementation with orally-administered glucan significantly improved some parameters of hematopoiesis.

Full Text: PDF HTML

Refbacks

  • There are currently no refbacks.